CathRx is fast becoming a global leader in ablation technology. We have harnessed next-generation technology to develop a patented, advanced & modular ablation platform. Our platform is a unique multi-indication ablation solution that has been designed in partnership with the world's leading physicians and brought to life by our engineering team, headquartered in Sydney, Australia. We believe catheter therapeutics are the future of healthcare, and our mission is to utilise our platform to change the lives of patients & their families all around the world.
| Website | http://www.cathrx.com |
| Revenue | $5.5 million |
| Employees | 36 (24 on RocketReach) |
| Founded | 1999 |
| Phone | +1 650-692-3500 |
| Technologies |
JavaScript
,
HTML
,
PHP
+5 more
(view full list)
|
| Industry | Medical Devices, Therapeutic Devices, Other Devices and Supplies, EP Catheters, Cardiac Catheters, Advanced AF Ablation, Modular Catheters, Environmentally-friendly cardiac catheters |
| Keywords | Medical Technology, Ablation Technology, Healthcare Technology, Medical Devices, Minimally Invasive Surgery, Advanced Medical Technology, Energy Based Surgery, Innovative Medical Technology, Surgical Tools, Radiofrequency Ablation, Surgical Innovation |
| Competitors | Siemens Healthineers, Johnson & Johnson, Medtronic, Abbott, Bayer, Philips, Cardinal Health, Boston Scientific, Cook Medical, Terumo +37 more (view full list) |
Looking for a particular CathRx Limited employee's phone or email?
The CathRx Limited annual revenue was $5.5 million in 2026.
Ian Fong is the CEO of CathRx Limited.
24 people are employed at CathRx Limited.
CathRx Limited is based in Sydney, New South Wales.